Wire Stories

Genius Group Ltd. Announces 60.68% Revenue Growth for the Nine Months Ended September 30, 2022 and Expansion of Gross Margin on a Pro Forma Basis to 47.33%

SINGAPORE--(BUSINESS WIRE)--$GNS #GNS--Genius Group Limited (�Genius Group� or the �Company�) (NYSE American: GNS), a leading entrepreneur Edtech and education group,…

2 years ago

AI and cloud tech leader CloudMile is empowering local organizations, leveraging Google infrastructure and nurturing local tech talent in Malaysia…

2 years ago

AI and cloud tech leader CloudMile is empowering local organizations, leveraging Google infrastructure and nurturing local tech talent in Malaysia…

2 years ago

Pulmonx Receives Japanese MHLW Approval of Zephyr Endobronchial Valve for the Treatment of Severe COPD/Emphysema

Approval of First Minimally Invasive Treatment Option in Japan that Helps Patients with Advanced Disease Breathe Easier and Have a…

2 years ago

Genius Group Ltd. Announces 60.68% Revenue Growth for the Nine Months Ended September 30, 2022 and Expansion of Gross Margin on a Pro Forma Basis to 47.33%

SINGAPORE--(BUSINESS WIRE)--$GNS #GNS--Genius Group Limited (�Genius Group� or the �Company�) (NYSE American: GNS), a leading entrepreneur Edtech and education group,…

2 years ago

Genius Group Ltd. Announces 60.68% Revenue Growth for the Nine Months Ended September 30, 2022 and Expansion of Gross Margin on a Pro Forma Basis to 47.33%

SINGAPORE--(BUSINESS WIRE)--$GNS #GNS--Genius Group Limited (�Genius Group� or the �Company�) (NYSE American: GNS), a leading entrepreneur Edtech and education group,…

2 years ago

Pulmonx Receives Japanese MHLW Approval of Zephyr Endobronchial Valve for the Treatment of Severe COPD/Emphysema

Approval of First Minimally Invasive Treatment Option in Japan that Helps Patients with Advanced Disease Breathe Easier and Have a…

2 years ago

Pulmonx Receives Japanese MHLW Approval of Zephyr Endobronchial Valve for the Treatment of Severe COPD/Emphysema

Approval of First Minimally Invasive Treatment Option in Japan that Helps Patients with Advanced Disease Breathe Easier and Have a…

2 years ago

3D Emphasizes the Need for Substantial Board Change at Fuji Soft

Believes Fuji Soft�s Recent Commitments to Address the Company�s Issues Are a Direct Response to 3D�s Campaign Notes the Importance…

2 years ago

3D Emphasizes the Need for Substantial Board Change at Fuji Soft

Believes Fuji Soft�s Recent Commitments to Address the Company�s Issues Are a Direct Response to 3D�s Campaign Notes the Importance…

2 years ago
Show more Posts
Show previous Posts